HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
KF 19514
inhibits both PDE1 and PDE4
Also Known As:
5-phenyl-3-(3-pyridil)methyl-3H-imidazo(4,5-c)(1,8)naphthyridin-4(5H)-one; KF-19514
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
Fused-Ring Heterocyclic Compounds
2-Ring Heterocyclic Compounds
Naphthyridines: 2
KF 19514: 1
Related Diseases
1.
Asthma (Bronchial Asthma)
05/26/1997 - "
These results suggest that although both inhibitors of phosphodiesterase III and phosphodiesterase IV have a bronchodilator or bronchoprotective effect, phosphodiesterase IV inhibitors such as KF-19514 may be more useful for asthma treatment because KF-19514 had an anti-allergic effect in addition to the functional bronchodilator activity.
"
Related Drugs and Biologics
1.
Type 4 Cyclic Nucleotide Phosphodiesterases
2.
Type 3 Cyclic Nucleotide Phosphodiesterases
3.
Anti-Allergic Agents (Antiallergic Agents)
4.
Bronchodilator Agents (Bronchodilators)